Loading: 100%
VERTEX PHARMACEUTICALS INC / MA logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Cambridge, United States of AmericaCambridge, United States of Americano data available
Employees 2,150 (as per Q1 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker VRTXno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17050100150200
datesClosing price (adj.)
13.10.2017152.91
11.10.2017154.02
04.10.2017152.51
27.09.2017149.00
20.09.2017152.72
13.09.2017156.80
06.09.2017157.08
30.08.2017156.29
23.08.2017153.25
16.08.2017151.37
09.08.2017152.58
02.08.2017157.55
26.07.2017163.42
19.07.2017159.76
12.07.2017131.44
05.07.2017129.00
27.06.2017129.23
20.06.2017126.33
13.06.2017122.49
06.06.2017127.72
30.05.2017120.39
23.05.2017116.59
16.05.2017118.09
09.05.2017116.63
02.05.2017118.47
25.04.2017117.27
18.04.2017114.65
11.04.2017114.23
04.04.2017112.29
28.03.201789.67
21.03.201789.50
14.03.201792.74
07.03.201791.32
28.02.201790.62
21.02.201786.55
14.02.201788.91
07.02.201786.84
31.01.201785.87
24.01.201782.24
17.01.201781.55
10.01.201782.93
03.01.201774.89
27.12.201675.19
19.12.201676.30
12.12.201676.08
05.12.201675.55
28.11.201686.90
21.11.201689.05
14.11.201694.42
07.11.201683.22
31.10.201675.86
24.10.201678.73
17.10.201680.50
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
152.91n/a
Market Capitalisation
in million USD
38,085n/a
Enterprise Value
in million USD
37,491n/a
Common Shares Outstanding
as per Apr 21, 2017
249,068,782n/a
Preferred Shares Outstanding
as per Apr 21, 2017
n/a
Average Basic Shares Outstanding
TTM
245,233,250n/a
Average Diluted Shares Outstanding
TTM
245,902,250n/a
Index Membership
n/a
Business Summary
Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 1,661n/a
Gross Profit 1,452n/a
Operating Income -81n/a
EBITDA -19n/a
Net Profit -219n/a
Balance Sheet
Cash and Cash Equivalents 1,128n/a
Receivables 182n/a
Total Current Assets 1,502n/a
PP&E 688n/a
Total Assets 2,610n/a
Accounts Payable 51n/a
Current Debt 316n/a
Total Current Liabilities 723n/a
Long-Term Debt 32n/a
Total Liabilities 1,401n/a
Total Equity 1,208n/a
Cash Flow
Depreciation & Amortisation 62n/a
Change in Working Capital 8n/a
Operating Cash Flow 121n/a
Net Change in PP&E and Intangibles -54n/a
Investing Cash Flow -248n/a
Dividends Paid 0n/a
Financing Cash Flow 92n/a
Total Change in Cash -37n/a
Free Cash Flow -88n/a
Profitability Ratios
Gross Margin 87.4%n/a
Operating Margin -4.9%n/a
Net Profit Margin -11.2%n/a
Return on Equity -15.4%n/a
Return on Assets -7.1%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA -1,957.53n/a
EV/Sales 22.57n/a
Book to Market Value 0.03n/a
Other Ratios
Current Ratio 207.8%n/a
Liabilities to Equity Ratio 116.0%n/a
Debt to Assets Ratio 13.3%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
176
102
143
1,411
1,527
1,212
580
1,032
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
0
0
0
-64
-237
-89
-40
-117
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
176
102
143
1,347
1,290
1,123
541
915
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-634
-695
-838
-1,125
-1,242
-1,280
-1,182
-1,380
Selling, General & Administrative
-101
-130
-188
-401
-433
-356
-305
-377
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-517
-550
-637
-708
-766
-882
-856
-996
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
-16
-14
-13
-17
-43
-41
-21
-7
Operating Income (Loss)
-458
-593
-695
222
49
-157
-641
-465
Non-Operating Income (Loss)
3
-10
-59
-53
-15
-16
-42
-91
Interest Expense, net
3
-8
-17
-38
-15
-23
-73
-84
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
-2
-41
-16
0
7
30
-7
Pretax Income (Loss), Adjusted
-456
-603
-753
168
34
-173
-684
-556
Abnormal Gains (Losses)
-4
-39
-2
-108
-2
-453
-51
-2
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
-460
-642
-755
60
32
-626
-735
-558
Income Tax (Expense) Benefit, net
0
0
0
-19
0
122
-7
-30
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-460
-642
-755
41
32
-504
-742
-588
Net Extraordinary Gains (Losses)
0
0
0
0
-83
-184
-1
0
Discontinued Operations
0
0
0
0
-83
-184
-1
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-460
-642
-755
41
-51
-688
-743
-588
Minority Interest
0
0
0
-12
-56
243
4
32
Net Income
-460
-642
-755
30
-107
-445
-739
-556
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-460
-642
-755
30
-107
-445
-739
-556
Remarks
restated on Feb 17, 2011 n/a
calculated values,
restated on Feb 22, 2012 n/a
calculated values,
restated on Mar 1, 2013 n/a
calculated values,
restated on Feb 11, 2014 n/a
calculated values,
restated on Feb 13, 2015 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
Balance SheetBS data quality: 98% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
1,285
1,031
969
1,321
1,465
1,387
1,042
Cash & Cash Equivalents
n/a
447
243
475
489
569
625
715
Short Term Investments
n/a
838
788
494
832
896
762
328
Accounts & Notes Receivable
n/a
10
13
183
143
86
76
174
Accounts Receivable, Net
n/a
10
13
183
143
86
76
174
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
0
0
112
30
14
31
57
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
13
13
67
95
24
53
134
Prepaid Expenses
n/a
13
13
15
25
24
44
55
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
52
70
0
8
79
Total Current Assets
n/a
1,307
1,057
1,331
1,590
1,589
1,547
1,407
Property, Plant & Equipment, Net
n/a
62
72
133
434
697
716
698
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
586
596
740
736
34
72
394
Intangible Assets
n/a
0
0
0
0
0
0
0
Goodwill
n/a
26
26
31
31
31
40
50
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
560
570
709
705
3
32
343
Total Noncurrent Assets
n/a
648
668
873
1,170
730
788
1,091
Total Assets
n/a
1,955
1,725
2,204
2,759
2,319
2,335
2,499
Liabilities and owners' equity
Payables & Accruals
n/a
156 156313000
174 173727000
318 317829000
366 366176000
320 320404000
281 280870000
381 380762000
Accounts Payable
n/a
37 36989000
36 35851000
75 74642000
101 101292000
49 49327000
71 71194000
75 74942000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
1 571000
3 3462000
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
119 118753000
134 134414000
243 243187000
265 264884000
271 271077000
210 209676000
306 305820000
Short Term Debt
n/a
32 32071000
137 136991000
12 12075000
14 14422000
17 16893000
32 32012000
87 86841000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
96 96499000
164 164065000
62 62444000
52 52026000
61 60532000
55 55372000
39 38564000
Deferred Revenue
n/a
75 74956000
75 74619000
45 45037000
28 27566000
22 21510000
17 17468000
16 16296000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
22 21543000
89 89446000
17 17407000
24 24460000
39 39022000
38 37904000
22 22268000
Total Current Liabilities
n/a
285 284883000
475 474783000
392 392348000
433 432624000
398 397829000
368 368254000
506 506167000
Long Term Debt
n/a
122 121765000
400 400000000
400 400000000
415 415170000
49 48754000
320 319862000
267 266786000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
452 452494000
347 346690000
446 446420000
677 677112000
516 516053000
550 550380000
632 632006000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
226 225575000
160 160049000
118 118095000
96 96242000
49 49459000
28 27808000
10 9714000
Deferred Tax Liabilities
n/a
160 160278000
160 160278000
244 243707000
280 280367000
0 0
15 15044000
110 110439000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
67 66641000
26 26363000
85 84618000
301 300503000
467 466594000
508 507528000
512 511853000
Total Noncurrent Liabilities
n/a
574 574259000
747 746690000
846 846420000
1,092 1092282000
565 564807000
870 870242000
899 898792000
Total Liabilities
n/a
859 859142000
1,221 1221473000
1,239 1238768000
1,525 1524906000
963 962636000
1,238 1238496000
1,405 1404959000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
3,787 3786769000
3,949 3949449000
4,203 4202731000
4,522 4521597000
5,324 5323606000
5,780 5779539000
6,200 6199927000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-2,690 -2689783000
-3,444 -3444409000
-3,415 -3414835000
-3,522 -3521867000
-3,967 -3966895000
-4,705 -4705450000
-5,262 -5261784000
Other Equity
n/a
-1 -640000
-1 -1067000
-1 -1053000
-1 -550000
0 -306000
1 917000
2 1824000
Equity Before Minority Interest
n/a
1,096 1096346000
504 503973000
787 786843000
999 999180000
1,356 1356405000
1,075 1075006000
940 939967000
Minority Interest
n/a
0 0
0 0
179 178669000
235 235202000
0 0
21 21177000
154 153661000
Total Equity
n/a
1,096 1096346000
504 503973000
966 965512000
1,234 1234382000
1,356 1356405000
1,096 1096183000
1,094 1093628000
Total Liabilities & Equity
n/a
1,955 1955488000
1,725 1725446000
2,204 2204280000
2,759 2759288000
2,319 2319041000
2,335 2334679000
2,499 2498587000
Remarks restated on n/a restated on Feb 17, 2011 n/a restated on Feb 22, 2012 n/a restated on Mar 1, 2013 n/a restated on Feb 11, 2014 n/a restated on Feb 13, 2015 n/a restated on Feb 16, 2016 n/a restated on Oct 31, 2016 n/a
Cash Flow StatementCF data quality: 91% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-460
-642
-755
41
-51
-688
-743
-588
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
32
30
30
35
38
48
63
62
Non-Cash Items
62
125
153
267
256
878
177
243
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
139
59
-64
-200
25
-299
-71
-83
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
-226
-428
-635
144
268
-61
-573
-365
Change in Fixed Assets & Intangibles
-32
-23
-38
-95
-71
-51
-61
-125
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-328
-398
50
294
-338
-64
134
434
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
-87
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
-1
1
-5
13
-17
3
9
-40
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-361
-509
7
212
-426
-113
82
269
Dividends Paid
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-20
0
0
-155
-3
-16
-21
-20
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
362
999
33
125
192
266
275
186
Increase in Capital Stock
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
Other Financing Activities
279
0
392
-94
-17
-1
296
23
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
621
999
425
-124
172
248
549
189
Net Cash Before Disc. Operations and FX
34
63
-203
232
14
75
58
92
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
34
63
-203
232
14
75
58
92
Effect of Foreign Exchange Rates
0
-5
0
0
0
5
-2
-3
Net Changes in Cash
33
58
-203
232
14
80
56
90
Remarks
restated on Feb 17, 2011 n/a
calculated values,
restated on Feb 22, 2012 n/a
calculated values,
restated on Mar 1, 2013 n/a
calculated values,
restated on Feb 11, 2014 n/a
calculated values,
restated on Feb 13, 2015 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo